Treatment of HR+ adjuvant breast cancer FOI request

The request was successful.

Dear Great Western Hospitals NHS Foundation Trust,

I would be grateful if you could please answer the following question:

Over the latest 12 months of data that you have access to, how many patients who were diagnosed with HR+ adjuvant breast cancer received trastuzumab monotherapy?

Thank you

Yours faithfully,
Oliver Caswell

Great Western Hospitals NHS Foundation Trust

1 Attachment

Dear Oliver

Please see attached an acknowledgement of your request.

Best regards
FOI Team, Great Western Hospitals NHS Foundation Trust

══════════════════════════════════════════════════════════════════════════

┌────────────────────────────────────────────────────────────────────────┐
│ Double Click on Above Link to View Attachment │
└────────────────────────────────────────────────────────────────────────┘

show quoted sections

Great Western Hospitals NHS Foundation Trust

1 Attachment

Good Morning Oliver

Please see attached the response to your request.

Best regards
FOI Team, Great Western Hospitals NHS Foundation Trust

══════════════════════════════════════════════════════════════════════════

┌────────────────────────────────────────────────────────────────────────┐
│ Double Click on Above Link to View Attachment │
└────────────────────────────────────────────────────────────────────────┘

show quoted sections